On October 5, 2015 Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, reported that there will be seven poster presentations featured at American Society for Human Genetics (ASHG) meeting being held Oct. 6 to 10, 2015 in Baltimore, Md (Press release, Myriad Genetics, OCT 5, 2015, View Source [SID:1234507643]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

"At Myriad, we are passionately committed to providing the most accurate hereditary cancer tests through extensively validated laboratory and variant interpretation processes. We have spent almost two decades of research to provide the most sophisticated and comprehensive variant classification program," said Rick Wenstrup, M.D., chief medical officer, Myriad Genetics. "We look forward to presenting these seven new studies at ASH (Free ASH Whitepaper)G as we continue to advance the state-of-the-art in variant classification with innovative new approaches."

A list of the Myriad presentations at ASH (Free ASH Whitepaper)G (#ASHG15) follows:

Poster Presentations

Title: RNA functional studies for the classification of germline variants of uncertain significance that may impair splicing.
Date: Wednesday, Oct. 7, 2015: 5:00 to 6:00 p.m. ET.
Location: Poster 2639W.

Title: No evidence for a difference in the severity of cancer history for carriers of missense versus truncating pathogenic variants in ATM.
Date: Thursday, Oct. 8, 2015: 12:00 to 1:00 p.m. ET.
Location: Poster 2750T.

Title: Detection of large rearrangements in a pan-cancer gene panel using next generation sequencing.
Date: Thursday, Oct. 8, 2015: 12:00 to 1:00 p.m. ET.
Location: Poster 2018T.

Title: Comparison of a literature search algorithm and curated publication database with the literature content of other locus specific databases.
Date: Thursday, Oct. 8, 2015: 12:00 to 1:00 p.m. ET.
Location: Poster 1739T.

Title: Analytical validation of a saliva collection and DNA extraction protocol increases accessibility to hereditary pan-cancer panel testing.
Date: Thursday, Oct. 8, 2015: 12:00 to 1:00 p.m. ET.
Location: Poster 1985T.

Title: Identification of retrotransposon insertion mutations in hereditary cancer.
Date: Thursday, Oct. 8, 2015: 12:00 to 1:00 p.m. ET.
Location: Poster 2592T.

Title: Does this patient need to be tested for Lynch Syndrome? Assessing the reliability of family history for ascertainment.
Date: Friday, Oct. 9, 2015: 11:45 a.m. to 12:45 p.m. ET.
Location: Poster 2082F.
For more information about these presentations, including a complete list of abstracts and posters, please visit the ASH (Free ASH Whitepaper)G website at www.ashg.org/2015meeting/pages/online-planner.shtml.